Dihydropyrimidine dehydrogenase and fluoropyrimidines: a review of current dose adaptation practices and the impact on the future of personalized medicine using 5-fluorouracil

By Boisdron-Celle Michèle   Biason Paola   Gamelin Erick   Morel Alain  

Colorectal Cancer, Vol. 2, Iss. 6, 2013-12 ,pp. : 549-558

Future Medicine

Access to resources Recommend Favorite

Hydroxyurea, 5-Fluorouracil Infusion, and Cisplatin Adjunct to Radiation Therapy in Cervical Carcinoma: A Phase I-II Trial of the Gynecologic Oncology Group

By Stehman F.B.   Bundy B.N.   Kucera P.R.   Deppe G.   Reddy S.   O'Connor D.M.  

Gynecologic Oncology, Vol. 66, Iss. 2, 1997-08 ,pp. : 262-267

Elsevier

Access to resources Recommend Favorite

Phase II trial of cisplatin, 5-fluorouracil, and interferon- -2B as first line treatment of advanced urothelial cancer

By Bazarbashi S.   Pai C.   Raja M.A.   Rahal M.   Ezzat A.   Hanash K.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 3, 2003-05 ,pp. : 185-189

Elsevier

Access to resources Recommend Favorite

Final Results of a Phase III Clinical Trial on Adjuvant Intraportal Infusion with Heparin and 5-Fluorouracil (5-FU) in Resectable Colon Cancer (EORTC GITCCG 1983-1987)

By Nitti D.   Wils J.   Sahmoud T.   Curran D.   Couvreur M.L.   Lise M.   Rauschecker H.   Guimaraes dos Santos J.   Stremmel W.   Roelofsen F.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1209-1215

Elsevier

Access to resources Recommend Favorite

Phase II clinical trial of advanced and metastatic gastric cancer based on continuous infusion of 5-fluorouracil combined with epirubicin and oxaliplatin

By Zhu Xiaodong   Leaw Jiin   Gu Weilie   Qian Yiying   Du Hongyu   Wang Biyun   Hong Xiaonan   Yin Jiliang  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 9, 2008-09 ,pp. : 929-936

Springer Publishing Company

Access to resources Recommend Favorite